23 reports

  • for Licensing Deals Valued Above $100m

Albireo Pharma Inc.

  • Dermatological Condition
  • Dermatology
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Melanoma Drug Market, Global, All Pipeline Products, 2016 (Part 3)

Part ##: Distribution Models for Biologics and other Specialty Pharmaceutical Products.

  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company
  • Incyte Corporation
  • Merck & Co., Inc.
  • Source: Ariad Pharmaceuticals, Incyte Corp, CancerReasearchAnalytics.com
  • Source: Ariad Pharmaceuticals, Incyte Corp, CancerResearchAnalytics.com
  • Pharmaceutical
  • Europe
  • ARIAD Pharmaceuticals, Inc.
  • Incyte Corporation
  • Otsuka Pharmaceutical Co., Ltd.

Pancreatic cancer

4546 5000 3864

Pharmaceuticals Policy and Law, ##, ##-##.

  • Pharmaceutical
  • Europe
  • Japan
  • World
  • Incyte Corporation

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • OTHER DRUGS IN DEVELOPMENT FOR MF, 2016
  • 9.2 COMMERCIAL BENCHMARK OF KEY PIPELINE DRUGS
  • Pharmaceutical
  • Therapy
  • Japan
  • Forecast
  • Incyte Corporation
  • 01. Executive Summary
  • 18. Vendor Landscape

It is ranked as one of the top ## companies in the Pharmaceutical industry.

  • Blood Disease
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • Incyte Corporation
  • 8.2 LATE-STAGE DRUGS IN CLINICAL DEVELOPMENT
  • PRODUCT PROFILE - INCB40093 (+INCB39110)

PHARMA JAPAN WEB.

  • Epidemiology
  • Hospital
  • Pharmaceutical
  • Therapy
  • Incyte Corporation

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd
  • SMALL MOLECULES COMPETITIVE LANDSCAPE
  • SMALL MOLECULES

CALIORNIA FRANCE HEADQUART ER S COMPANY- INNATE PHARMA S. A.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Agenus Inc.
  • Incyte Corporation
  • IMMUNE CHECKPOINT INHIBITORS: DISTRIBUTION BY DRUG DEVELOPERS
  • NOVEL IMMUNE CHECKPOINT INHIBITORS PIPELINE: DISTRIBUTION BY COMPANIES

IOMET PHARMA.

  • HIV Antiviral
  • Pharmaceutical
  • Therapy
  • Demand
  • Incyte Corporation

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Dormant Products
  • CTP-543 - DRUG PROFILE

PIPELINE BY ACLARIS THERAPEUTICS INC, H## 2017 ASTELLAS PHARMA INC Astellas Pharma Inc (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of

  • Arthritis
  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Incyte Corp, Pharmaceuticals & Healthcare, Key Facts, 2016
  • INCYTE ACQUIRES ARIAD PHARMA (LUXEMBOURG) FOR USD140 MILLION
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Incyte Corporation
  • FEATURED NEWS & PRESS RELEASES
  • RUXOLITINIB PHOSPHATE - DRUG PROFILE

ASTELLAS PHARMA INC Astellas Pharma Inc (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Incyte Corporation
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • EPACADOSTAT - DRUG PROFILE

Redx Pharma Plc (Redx Pharma) formerly Redx Pharma Limited is a biotechnology company that specializes in early stage, small molecule therapeutics.

  • Cancer
  • Pharmaceutical
  • Research And Development
  • Therapy
  • Incyte Corporation
  • RUXOLITINIB PHOSPHATE - DRUG PROFILE

PIPELINE BY NOVARTIS AG, H## 2017 NS PHARMA INC NS Pharma Inc (NS Pharma), a subsidiary of Nippon Shinyaku Co Ltd, is a pharmaceutical company that develops drugs for muscular disorders.

  • Arthritis
  • Hospital
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • RUXOLITINIB PHOSPHATE - DRUG PROFILE

In September 2009, Pharma Essentia out licensed EU rights of the drug candidate to AOP Orphan Pharmaceutical (AOP).

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • duration of response, overall response rate at day 14, 56, and 100, non-relapse mortality and safety.

PIPELINE BY ASTRAZENECA PLC, H## 2017 BRISTOL-MYERS SQUIBB COMPANY PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H## 2017 CELON PHARMA SA Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

CANCER ANOREXIA-CACHEXIA SYNDROME - PIPELINE BY PSIOXUS THERAPEUTICS LTD, H## 2017 RAQUALIA PHARMA INC RaQualia Pharma Inc (RaQualia) is a pharmaceutical company that discovers, develops and markets pharmaceutical compounds.

  • Cancer
  • Pharmaceutical
  • United States
  • Product Initiative
  • Incyte Corporation
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES
  • GALENA BIOPHARMA INC

AOP ORPHAN PHARMACEUTICALS AG ESSENTIAL THROMBOCYTHEMIA - PIPELINE BY AOP ORPHAN PHARMACEUTICALS AG, H## 2017 F.

  • Blood Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Incyte Corporation
  • Jul 05, 2012
  • Incyte Corporation Overview

In collaboration with Incyte, Novartis International Pharmaceutical Ltd.

  • Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Incyte Corporation